PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2026 Earnings Call Transcript
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2026 Earnings Call Transcript April 29, 2026PROCEPT BioRobotics Corporation misses on earnings expectations.
Procept Biorobotics Corp (PRCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 779 | $19,483 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.42 | 1,300 | $33,042.49 | 426,262 | 2026-03-09 | Filing | |
| $24.91 | 53,818 | $1,340,348.05 | 424,962 | 2026-03-09 | Filing | |
| $24.08 | 43,581 | $1,049,500.21 | 371,144 | 2026-03-09 | Filing | |
| $24.10 | 53,763 | $1,295,790.45 | 327,563 | 2026-03-06 | Filing | |
| $23.33 | 106,554 | $2,485,713.02 | 273,800 | 2026-03-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.15 | 2,332 | $60,972.47 | 105,354 | 2026-03-19 | Filing | |
| $25.82 | 3,031 | $78,258.30 | 107,686 | 2026-03-19 | Filing | |
| $28.15 | 304 | $8,558.57 | 110,717 | 2026-03-17 | Filing | |
| $28.15 | 706 | $19,876.16 | 151,558 | 2026-03-17 | Filing | |
| $26.74 | 145 | $3,877.00 | 111,021 | 2026-03-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,421,362 | $60,558,264 | 0% | |
| 2. | 2,399,067 | $60,000,666 | 0% | |
| 3. | 2,160,587 | $54,036,268 | 1.46% | |
| 4. | 973,502 | $24,347,285 | 0.02% | |
| 5. | 504,493 | $12,617,370 | 0% |
News See All
10 Best Robotics Stocks to Buy Under $30
On April 19, 2026, dozens of Chinese humanoid robots lined up for a half-marathon in Beijing. Several of them crossed the finish line more than ten minutes ahead of the human winners.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the PROCEPT BioRobotics Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory
We came across a bullish thesis on PROCEPT BioRobotics Corporation on Notes From The Beauty Contest’s Substack by Crashkolnikov.
10 Overlooked Small Cap Stocks to Buy Now
On January 2, Royce Investment released its Small-Cap Recap Q4 2025 report, highlighting that the last quarter of 2025 saw the Russell 2000 and Russell Microcap Indexes each in positive territory.
Truist Maintains Buy Rating on Procept BioRobotics (PRCT) Amid MedTech Sector Rotation
Procept BioRobotics Corporation (NASDAQ:PRCT) is one of the best up and coming stocks to buy according to Wall Street.
10 Best Up and Coming Stocks to Buy According to Wall Street
On December 26, Thomson Nguyen, Saga Ventures co-founder and managing partner, joined 'Squawk Box' on CNBC to discuss the resurgence of the IPO market following a strong 2025 performance.
Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT)
On December 12, UBS analyst Danielle Antalffy initiated coverage with a bullish rating on Procept Biorobotics Corp. (NASDAQ:PRCT). She rated the stock as a Buy and estimated a target price of $62.
15 Most Promising Mid-Cap Healthcare Stocks Under $50
Traditionally, healthcare stocks have been considered defensive, offering strong immunity to business cycles.
10 Fast-Growing Small Cap Stocks to Buy According to Analysts
On October 1, Francis Gannon, Co-Chief Investment Officer and Managing Director at Royce Investment Partners, released a report analyzing small-cap performance during the third quarter of 2025.
Hedge Fund Resource Center